[Evaluation of the activity of monoclonal anti-A-, anti-B-antibodies]

The activity and specificity of monoclonal antibodies (MCA) anti-A and anti-B, which were presented for testing at the 4th International Workshop on Monoclonal Antibodies to Red Blood Cells and Related Antigens, Paris, 2001, were studied. First, the activity of antibodies with erythrocytes with good expression of antigens A and B (controls) was tested. Then, the activity of MCA with erythrocytes with a weak expression of erythrocyte antigens was tested and the reaction was, after that, estimated in percent versus the controls. According to the results, the activity of interaction of anti-B antibodies with the phenotype A2 erythrocytes was lower versus such activity with the phenotype A1 erythrocytes. It is noteworthy, that all samples of antibodies, except for series 5, 6 and 10, were more active with the phenotype A2 erythrocytes versus the phenotype A2B erythrocytes. All tested samples of anti-B-antibodies possessed a high activity (within a range of 85-100%) and were effective in the detection of antigen B. The activity of MCA anti-AB with erythrocytes A2 was lower versus such activity with erythrocytes A and B and made 45-85%. MCAs of anti-A and of anti-B significantly differed by their ability to interact with erythrocytes A2. This may generate problems in using the above antibodies for making the typing reagents to be applied in routine blood group tests.

Related Concept Videos

Affinity and Avidity01:41

Affinity and Avidity

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...